US Patent 10196614 Compositions and methods for antigen targeting to CD180
Patent 10196614 was granted and assigned to University of Washington on February, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 27 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+172 characters)
Article
Patent abstract
The present limiting provides compositions of CD 180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.
Edits on 2 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Edward Clark0
Jay Wesley Chaplin0
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
101966140
Date of Patent
February 5, 2019
0Patent Application Number
144266350
Date Filed
September 16, 2013
0Patent Citations Received
Patent Primary Examiner
Edits on 23 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 11 Jan, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 23 Sep, 2022
Golden AI
Edits on 23 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 20 Jul, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 1 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 24 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10196614 Compositions and methods for antigen targeting to CD180
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10196614
Date of patent
February 5, 2019
Patent application number
14426635
Date Filed
September 16, 2013
Patent primary examiner
Find more entities like US Patent 10196614 Compositions and methods for antigen targeting to CD180
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
